Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice.
BACKGROUND
Protective host responses to respiratory pathogens are typically characterized by inflammation. However, lung inflammation is not always protective and it may even become deleterious to the host. We have recently reported substantial protection against Streptococcus pneumoniae (pneumococcal) pneumonia by induction of a robust inflammatory innate immune response to an inhaled bacterial lysate. Conversely, the allergic inflammation associated with asthma has been proposed to promote susceptibility to pneumococcal disease. This study sought to determine whether preexisting allergic lung inflammation influences the progression of pneumococcal pneumonia or reduces the inducibilty of protective innate immunity against bacteria.


METHODS
To compare the effect of different inflammatory and secretory stimuli on defense against pneumonia, intraperitoneally ovalbumin-sensitized mice were challenged with inhaled pneumococci following exposure to various inhaled combinations of ovalbumin, ATP, and/or a bacterial lysate. Thus, allergic inflammation, mucin degranulation and/or stimulated innate resistance were induced prior to the infectious challenge. Pathogen killing was evaluated by assessing bacterial CFUs of lung homogenates immediately after infection, the inflammatory response to the different conditions was evaluated by measurement of cell counts of bronchoalveolar lavage fluid 18 hours after challenge, and mouse survival was assessed after seven days.


RESULTS
We found no differences in survival of mice with and without allergic inflammation, nor did the induction of mucin degranulation alter survival. As we have found previously, mice treated with the bacterial lysate demonstrated substantially increased survival at seven days, and this was not altered by the presence of allergic inflammation or mucin degranulation. Allergic inflammation was associated with predominantly eosinophilic infiltration, whereas the lysate-induced response was primarily neutrophilic. The presence of allergic inflammation did not significantly alter the neutrophilic response to the lysate, and did not affect the induced bacterial killing within the lungs.


CONCLUSIONS
These results suggest that allergic airway inflammation neither promotes nor inhibits progression of pneumococcal lung infection in mice, nor does it influence the successful induction of stimulated innate resistance to bacteria.
Clement
Cecilia G
CG
Department of Pulmonary Medicine, The University of Texas M, D, Anderson Cancer Center, Houston, TX 77030, USA. cgmoron@utmb.edu
Tuvim
Michael J
MJ
Evans
Christopher M
CM
Tuvin
Daniel M
DM
Dickey
Burton F
BF
Evans
Scott E
SE
D000336:Aerosols; D000542:Alveolitis, Extrinsic Allergic / Q000150:complications / Q000382:microbiology* / Q000473:pathology; D000818:Animals; D000942:Antigens, Bacterial / Q000494:pharmacology; D015550:Cell Degranulation / Q000502:physiology; D018450:Disease Progression; D005260:Female; D006193:Haemophilus influenzae / Q000276:immunology; D007113:Immunity, Innate / Q000502:physiology*; D008168:Lung / Q000382:microbiology / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010641:Phenotype; D011008:Pneumococcal Infections / Q000150:complications / Q000382:microbiology*; D013534:Survival
D000336:Aerosols; D000942:Antigens, Bacterial